Genome-wide analysis of evolutionary markers of human influenza A(H1N1)pdm09 and A(H3N2) viruses may guide selection of vaccine strain candidates

Genome Biology and Evolution

Volumn 7, Issue 12, 2015, Pages 3472-3483

  Belanov, Sergei S ^a   Bychkov, Dmitrii ^a   Benner, Christian ^a   Ripatti, Samuli ^a,b   Ojala, Teija ^c   Kankainen, Matti ^a   Lee, Hong Kai ^d   Tang, Julian Wei Tze ^e   Kainov, Denis E ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^e UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

Evolutionary markers; Influenza vaccine; Influenza virus; Virus evolution

Indexed keywords

GENETIC MARKER; INFLUENZA VACCINE;

AMINO ACID SEQUENCE; GENETIC MARKER; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); MOLECULAR EVOLUTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; VIRUS GENOME;

AMINO ACID SEQUENCE; BASE SEQUENCE; EVOLUTION, MOLECULAR; GENETIC MARKERS; GENOME, VIRAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MOLECULAR SEQUENCE DATA;

EID: 84982152987     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evv240     Document Type: Article

References (52)

1. Bedford T, et al. 2014. Integrating influenza antigenic dynamics with molecular evolution. eLife 3:e01914.
2. Bhatt S, et al. 2013. The evolutionary dynamics of influenza A virus adaptation to mammalian hosts. Philos Trans R Soc London Ser B Biol Sci. 368:20120382.
3. Broberg E, et al. 2015. Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. Euro Surveill. 20:21023.
4. Corti D, et al. 2011. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850-856.
5. Drummond AJ, Ho SY, Phillips MJ, Rambaut, A. 2006. Relaxed phylogenetics and dating with confidence. PLoS Biol. 4:e88.
6. Du X, et al. 2012. Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation. Nat Commun. 3:709.
7. Dudas G, Bedford T, Lycett S, Rambaut, A. 2015. Reassortment between influenza B lineages and the emergence of a coadapted PB1-PB2-HA gene complex. Mol Biol Evol. 32:162-172.
8. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:1792-1797.
9. Ekiert DC, et al. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
10. Ekiert DC, et al. 2011. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843-850.
11. Ekiert DC, et al. 2012. Cross-neutralization of influenza A virusesmediated by a single antibody loop. Nature 489:526-532.
12. Elderfield RA, et al. 2014. Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom. J Virol. 88:13269-13283.
13. Flannery B, et al. 2015. Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015. MMWR Morb Mortal Wkly Rep. 64:10-15.
14. Forbes N, et al. 2013. Identification of adaptive mutations in the influenza A virus non-structural 1 gene that increase cytoplasmic localization and differentially regulate host gene expression. PLoS One 8:e84673.
15. Forbes NE, et al. 2012. Multifunctional adaptive NS1 mutations are selected upon human influenza virus evolution in the mouse. PLoS One 7:e31839.
16. Goldstein E, et al. 2015. Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003-2011. Influenza Other Respir Viruses 9:225-233.
17. Hayward AC, et al. 2014. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med. 2:445-454.
18. Holmes EC, et al. 2005. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol. 3:e300.
19. Job ER, et al. 2014. A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice. J Immunol. 192:271-281.
20. Kearse M, et al. 2012. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647-1649.
21. Koel BF, et al. 2013. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342:976-979.
22. Lee AJ, et al. 2015a. Diversifying selection analysis predicts antigenic evolution of 2009 pandemic H1N1 Influenza A virus in humans. J Virol. 89:5427-5440.
23. Lee HK, et al. 2015b. Predicting clinical severity based on substitutions near epitope A of influenza A/H3N2. Infect Genet Evol. 34:292-297.
24. Lozano R, et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095-2128.
25. Luksza M, Lassig M. 2014. A predictive fitness model for influenza. Nature 507:57-61.
26. Matsuzaki Y, et al. 2004. Genetic diversity of influenza B virus: the frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community. J Med Virol. 74:132-140.
27. Memoli MJ, et al. 2009. Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift. J Infect Dis. 200:1232-1241.
28. Mishel P, et al. 2015. Comparative analysis ofwhole-genome sequences of influenza A(H1N1)pdm09 viruses isolated from hospitalized and nonhospitalized patients identifies missense mutations that might be associated with patient hospital admissions in Finland during 2009 to 2014. Genome Announc. 3:e00676-15.
29. Murrell B, et al. 2013. FUBAR: a fast, unconstrained bayesian approximation for inferring selection. Mol Biol Evol. 30:1196-1205.
30. Neher RA, Bedford T. 2015. nextflu: real-time tracking of seasonal influenza virus evolution in humans. Bioinformatics 31:3546-3548.
31. Neher RA, Russell CA, Shraiman BI. 2014. Predicting evolution from the shape of genealogical trees. eLife 3:e03568.
32. Nelson MI, Holmes EC. 2007. The evolution of epidemic influenza. Nat Rev Genet. 8:196-205.
33. Nunes B, et al. 2008. Heterogeneous selective pressure acting on influenza B Victoria-and Yamagata-like hemagglutinins. J Mol Evol. 67:427-435.
34. Osterholm MT, Kelley NS, Sommer A, Belongia, EA. 2012. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 12:36-44.
35. Pautus S, et al. 2013. New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain. J Med Chem. 56:8915-8930.
36. Peterlin BM, Brogie JE, Price DH. 2012. 7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription. Wiley Interdiscip Rev RNA 3:92-103.
37. Plotkin JB, Dushoff J, Levin, SA. 2002. Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A. 99:6263-6268.
38. Reich S, et al. 2014. Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature 516:361-366.
39. Rondy M, et al. 2015. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill. 20:21011.
40. Simpson CR, et al. 2013. In Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study - exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine Southampton (UK). Health Services and Delivery Research, 1.10.
41. Smith DJ, et al. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376.
42. Smith GJ, et al. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122-1125.
43. Steinbruck L, Klingen, TR, McHardy, AC. 2014. Computational prediction of vaccine strains for human influenza A (H3N2) viruses. J Virol. 88:12123-12132.
44. Storey JD. 2002. A direct approach to false discovery rates. J Roy Stat Soc B. 64:479-498.
45. Strelkowa N, Lassig, M. 2012. Clonal interference in the evolution of influenza. Genetics 192:671-682.
46. Sun Y, et al. 2014. Naturally occurring mutations in the PA gene are key contributors to increased virulence of pandemic H1N1/09 influenza virus in mice. J Virol. 88:4600-4604.
47. Tharakaraman K, Sasisekharan, R. 2015. Influenza surveillance: 2014-2015 H1N1 "swine"-derived influenza viruses from India. Cell Host Microbe 17:279-282.
48. Tharakaraman K, et al. 2014. Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure. Cell HostMicrobe 15:644-651.
49. Uraki R, et al. 2013. Virulence determinants of pandemic A(H1N1)2009 influenza virus in a mouse model. J Virol. 87:2226-2233.
50. Valenciano M, et al. 2015. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine 33:2813-2822.
51. Vijaykrishna D, et al. 2014. The contrasting phylodynamics of human influenza B viruses. eLife 4:e05055.
52. Vijaykrishna D, et al. 2015. The contrasting phylodynamics of human influenza B viruses. eLife 4:e05055.